← Open Payments lookup

MELANIE HOPKINS: Open Payments

NPI 1528060845 · LISBON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,237 in 65 payments from 11 companies in 2025. Trend: 2023 $1,344 · 2024 $1,465 · 2025 $1,237

Food & beverage: $1,237
CompanyPaymentsAmount
Novo Nordisk Inc16$327
ABBVIE INC.17$238
GlaxoSmithKline, LLC.6$160
Phathom Pharmaceuticals, Inc.8$154
Lundbeck LLC3$80
Amgen Inc.4$66
PFIZER INC.3$61
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$54
Otsuka America Pharmaceutical, Inc.2$35
Boehringer Ingelheim Pharmaceuticals, Inc.2$34

Products named: Rybelsus, Ozempic, VOQUEZNA, VRAYLAR, REXULTI, UBRELVY, TRELEGY ELLIPTA, AREXVY.

Industry payments across CT — which companies pay providers there.